Evidence map›Paper›PMID 36543923›Full record

SynthesisMolecular psychiatry2023

African ancestry GWAS of dementia in a large military cohort identifies significant risk loci.

Richard Sherva, Rui Zhang, Nathan Sahelijo, Gyungah Jun, Tori Anglin, Catherine Chanfreau, Kelly Cho, Jennifer R Fonda, J Michael Gaziano, Kelly M Harrington and 18 more

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Molecular psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 3 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 3 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Genetic and environmental risk factors for dementia in African adults: A systematic review.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Immune dysfunction in Alzheimer disease.Nature reviews. Neuroscience · 2026
    Review
  9. IsmedRxiv : the preprint server for health sciences · 2026
    Article
  10. Analyses of plasma multi-omic data across ancestries identify novel pathways implicated in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Alzheimer's disease multi-ancestry genome-wide interaction and stratified study with smoking.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 8 institutions in 1 country.

Richard ShervaNational Center for PTSD, Behavioral Sciences Division, VA Boston Healthcare System, Boston, MA, USA.ORCID 0000-0003-2133-1493
Rui ZhangNational Center for PTSD, Behavioral Sciences Division, VA Boston Healthcare System, Boston, MA, USA.
Nathan SahelijoBoston University Chobanian & Avedisian School of Medicine, Biomedical Genetics, Boston, MA, USA.ORCID 0000-0003-1662-1007
Gyungah JunBoston University Chobanian & Avedisian School of Medicine, Biomedical Genetics, Boston, MA, USA.ORCID 0000-0002-3230-8697
Tori AnglinVA Informatics and Computing Infrastructure (VINCI), Salt Lake City, UT, USA.ORCID 0000-0002-9084-7111
Catherine ChanfreauVA Informatics and Computing Infrastructure (VINCI), Salt Lake City, UT, USA.ORCID 0000-0002-4663-8953
Kelly ChoMassachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, USA.
Jennifer R FondaDepartment of Psychiatry, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 02118, USA.
J Michael GazianoMassachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, USA.
Kelly M HarringtonMassachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, USA.
Yuk-Lam HoMassachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, USA.
William S KremenDepartment of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Elizabeth LitkowskiDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Julie LynchVA Informatics and Computing Infrastructure (VINCI), Salt Lake City, UT, USA.
Zoe NealeNational Center for PTSD, Behavioral Sciences Division, VA Boston Healthcare System, Boston, MA, USA.
Panos RoussosCenter for Disease Neurogenomics, Departments of Psychiatry and Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-4640-6239
David MarraMassachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, USA.
Jesse MezBoston University Chobanian & Avedisian School of Medicine, Biomedical Genetics, Boston, MA, USA.
Mark W MillerNational Center for PTSD, Behavioral Sciences Division, VA Boston Healthcare System, Boston, MA, USA.ORCID 0000-0001-6393-8563
David H SalatNeuroimaging Research for Veterans Center, VA Boston Healthcare System, Boston, MA, USA.
Debby TsuangGeriatric Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, USA.
Erika WolfNational Center for PTSD, Behavioral Sciences Division, VA Boston Healthcare System, Boston, MA, USA.ORCID 0000-0003-2666-2435
Qing ZengVA Washington DC Healthcare System, Washington, DC, USA.
Matthew S PanizzonDepartment of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Victoria C MerrittDepartment of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Lindsay A FarrerBoston University Chobanian & Avedisian School of Medicine, Biomedical Genetics, Boston, MA, USA.ORCID 0000-0001-5533-4225
Richard L HaugerDepartment of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Mark W LogueNational Center for PTSD, Behavioral Sciences Division, VA Boston Healthcare System, Boston, MA, USA. mark.logue@va.gov.ORCID 0000-0001-9347-7892
Boston University · USUniversity of California San Diego · USVA Boston Healthcare System · USBrigham and Women's Hospital · USNathan Kline Institute for Psychiatric Research · USVA Eastern Colorado Health Care System · USVA Puget Sound Health Care System · USWashington DC VA Medical Center · US

Funding

Alzheimer's Disease Genetics ConsortiumU01AG032984 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2024
$60.4M
The VETSA Longitudinal Twin Study of Cognition and Aging (VETSA 4)R01AG050595 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELMAN, JEREMY A, FRANZ, CAROL ELAINE · 2015 to 2024
$28.0M
The VETSA Longitudinal MRI Twin Study of Aging (VETSA MRI 4)R01AG076838 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ANDERS M DALE, Jeremy A Elman · 2022 to 2026
$8.7M
Postdoctoral Training Program in Stress and TraumaT32MH019836 · NIMH · TUFTS UNIVERSITY BOSTON · PI DENISE M. SLOAN · 1996 to 2026
$4.7M
Genetic Predictors, Transcriptomic Biomarkers, & Neurobiological Signatures of Resilience to Alzheimer's DiseaseR01AG064955 · NIA · UPSTATE MEDICAL UNIVERSITY · PI FENNEMA-NOTESTINE, CHRISTINE, GLATT, STEPHEN J · 2019 to 2023
$3.8M
Early Cognitive Impairment as a Function of Alzheimer’s Disease Genes and TraumaI01BX004192 · VA · VA BOSTON HEALTH CARE SYSTEM · PI LOGUE, MARK W · 2019 to 2024
–
Predictor Profiles of Opioid Use Disorders and Overdose Among Post-9/11 VeteransIK2CX002192 · VA · VA BOSTON HEALTH CARE SYSTEM · PI Jennifer R Fonda · 2022 to 2026
–
Clinical Manipulation of Testosterone and Its Impact on Dementia and HealthI01CX001727 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI HAUGER, RICHARD L · 2019 to 2023
–
BLRD VA I01 BX004192CSRD VA I01 CX001727CSRD VA IK2 CX002192NIA NIH HHS R01 AG050595NIA NIH HHS R01 AG064955NIA NIH HHS R01 AG076838NIA NIH HHS U01 AG032984NIMH NIH HHS T32 MH019836
6 · The paper itself

Abstract

While genome wide association studies (GWASs) of Alzheimer's Disease (AD) in European (EUR) ancestry cohorts have identified approximately 83 potentially independent AD risk loci, progress in non-European populations has lagged. In this study, data from the Million Veteran Program (MVP), a biobank which includes genetic data from more than 650,000 US Veteran participants, was used to examine dementia genetics in an African descent (AFR) cohort. A GWAS of Alzheimer's disease and related dementias (ADRD), an expanded AD phenotype including dementias such as vascular and non-specific dementia that included 4012 cases and 18,435 controls age 60+ in AFR MVP participants was performed. A proxy dementia GWAS based on survey-reported parental AD or dementia (n = 4385 maternal cases, 2256 paternal cases, and 45,970 controls) was also performed. These two GWASs were meta-analyzed, and then subsequently compared and meta-analyzed with the results from a previous AFR AD GWAS from the Alzheimer's Disease Genetics Consortium (ADGC). A meta-analysis of common variants across the MVP ADRD and proxy GWASs yielded GWAS significant associations in the region of APOE (p = 2.48 × 10

Indexed as

Alzheimer DiseaseBlack or African AmericanMilitary PersonnelAgedDatabases, GeneticDementiaGene Expression ProfilingGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansMiddle AgedPolymorphism, GeneticUnited States

Identifiers

PMID36543923
PMCPMC10066923
OpenAlexW4312128743

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.